{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:28:55Z","timestamp":1786494535875,"version":"build-2736575974"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":72,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100018712","name":"\u201cIuliu Ha\u0163ieganu\u201d University of Medicine and Pharmacy","doi-asserted-by":"crossref","award":["772\/24, 11 January 2023"],"award-info":[{"award-number":["772\/24, 11 January 2023"]}],"id":[{"id":"10.13039\/501100018712","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-55902-1","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T15:35:34Z","timestamp":1780328134000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Circulating ACE2 levels and ACE I\/D polymorphism in severe aortic stenosis"],"prefix":"10.1038","volume":"16","author":[{"given":"Denisa Bianca","family":"Mercean","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liviu\u0163a","family":"Budi\u015fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Ancu\u0163a","family":"Pop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioana","family":"Berindan-Neagoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Pop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adela Mihaela","family":"\u015eerban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen Stanca","family":"Melincovici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen Mihaela","family":"Mihu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,1]]},"reference":[{"key":"55902_CR1","doi-asserted-by":"publisher","first-page":"4635","DOI":"10.1093\/eurheartj\/ehaf194","volume":"46","author":"F Praz","year":"2025","unstructured":"Praz, F. et al. 2025 ESC\/EACTS Guidelines for the management of valvular heart disease. Eur. Heart J. 46, 4635\u20134736 (2025).","journal-title":"Eur. Heart J."},{"key":"55902_CR2","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1056\/NEJM199907153410302","volume":"341","author":"CM Otto","year":"1999","unstructured":"Otto, C. M., Lind, B. K., Kitzman, D. W., Gersh, B. J. & Siscovick, D. S. Association of Aortic-Valve Sclerosis with Cardiovascular Mortality and Morbidity in the Elderly. N. Engl. J. Med. 341, 142\u2013147 (1999).","journal-title":"N. Engl. J. Med."},{"key":"55902_CR3","first-page":"1","volume":"38","author":"KH Zheng","year":"2020","unstructured":"Zheng, K. H., Tzolos, E. & Dweck, M. R. Pathophysiology of Aortic Stenosis and Future Perspectives for Medical Therapy. Cardiol. Clin. 38, 1\u201312 (2020).","journal-title":"Cardiol. Clin."},{"key":"55902_CR4","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00036","author":"M Paul","year":"2006","unstructured":"Paul, M., Poyan Mehr, A. & Kreutz, R. Physiology of Local Renin-Angiotensin Systems. https:\/\/doi.org\/10.1152\/physrev.00036.2005.-Since doi:10.1152\/physrev.00036.2005.-Since. (2006)."},{"key":"55902_CR5","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.atherosclerosis.2011.01.018","volume":"216","author":"T Peltonen","year":"2011","unstructured":"Peltonen, T. et al. Pro)renin receptors and angiotensin converting enzyme 2\/angiotensin-(1\u20137)\/Mas receptor axis in human aortic valve stenosis. Atherosclerosis 216, 35\u201343 (2011).","journal-title":"Atherosclerosis"},{"key":"55902_CR6","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S1050-1738(02)00233-5","volume":"13","author":"GY Oudit","year":"2003","unstructured":"Oudit, G. Y., Crackower, M. A., Backx, P. H. & Penninger, J. M. The Role of ACE2 in Cardiovascular Physiology. Trends Cardiovasc. Med. 13, 93\u2013101 (2003).","journal-title":"Trends Cardiovasc. Med."},{"key":"55902_CR7","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1152\/ajpheart.00618.2005","volume":"289","author":"CM Ferrario","year":"2005","unstructured":"Ferrario, C. M., Trask, A. J. & Jessup, J. A. Invited Review Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1\u20137) in regulation of cardiovascular function. Am. J. Physiol. Heart Circ. Physiol. 289, 2281\u20132290 (2005).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"55902_CR8","doi-asserted-by":"crossref","unstructured":"Donoghue, M. et al. A Novel Angiotensin-Converting Enzyme\u2013Related Carboxypeptidase (ACE2) Converts Angiotensin I to Angiotensin 1\u20139. Circ Res 87, (2000).","DOI":"10.1161\/01.RES.87.5.e1"},{"key":"55902_CR9","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1172\/JCI116428","volume":"91","author":"M Paul","year":"1993","unstructured":"Paul, M., Wagner, J. & Dzau, V. J. Gene expression of the renin-angiotensin system in human tissues. Quantitative analysis by the polymerase chain reaction. J. Clin. Invest. 91, 2058\u20132064 (1993).","journal-title":"J. Clin. Invest."},{"key":"55902_CR10","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1161\/01.HYP.25.2.219","volume":"25","author":"M Falkenhahn","year":"1995","unstructured":"Falkenhahn, M. et al. Cellular Distribution of Angiotensin-Converting Enzyme After Myocardial Infarction. Hypertension 25, 219\u2013226 (1995).","journal-title":"Hypertension"},{"key":"55902_CR11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1741-7015-2-19","volume":"2","author":"AB Goulter","year":"2004","unstructured":"Goulter, A. B., Goddard, M. J., Allen, J. C. & Clark, K. L. ACE2 gene expression is up-regulated in the human failing heart. BMC Med. 2, 19 (2004).","journal-title":"BMC Med."},{"key":"55902_CR12","doi-asserted-by":"publisher","first-page":"30113","DOI":"10.1074\/jbc.M505111200","volume":"280","author":"DW Lambert","year":"2005","unstructured":"Lambert, D. W. et al. Tumor necrosis factor-\u03b1 convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2). J. Biol. Chem. 280, 30113\u201330119 (2005).","journal-title":"J. Biol. Chem."},{"key":"55902_CR13","first-page":"1280","volume":"19","author":"TE Walters","year":"2017","unstructured":"Walters, T. E. et al. Angiotensin converting enzyme 2 activity and human atrial fibrillation: Increased plasma angiotensin converting enzyme 2 activity is associated with atrial fibrillation and more advanced left atrial structural remodelling. Europace 19, 1280\u20131287 (2017).","journal-title":"Europace"},{"key":"55902_CR14","doi-asserted-by":"crossref","unstructured":"Ramchand, J., Patel, S. K., Srivastava, P. M., Farouque, O. & Burrell, L. M. Elevated plasma angiotensin converting enzyme 2 activity is an independent predictor of major adverse cardiac events in patients with obstructive coronary artery disease. PLoS One 13, (2018).","DOI":"10.1371\/journal.pone.0198144"},{"key":"55902_CR15","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.cardfail.2009.01.014","volume":"15","author":"S Epelman","year":"2009","unstructured":"Epelman, S. et al. Soluble Angiotensin-Converting Enzyme 2 in Human Heart Failure: Relation With Myocardial Function and Clinical Outcomes. J. Card Fail. 15, 565\u2013571 (2009).","journal-title":"J. Card Fail."},{"key":"55902_CR16","doi-asserted-by":"publisher","unstructured":"Oudit, G. Y. & Pfeffer, M. A. Plasma angiotensin-converting enzyme 2: Novel biomarker in heart failure with implications for COVID-19. European Heart Journal vol. 41 1818\u20131820 Preprint at (2020). https:\/\/doi.org\/10.1093\/eurheartj\/ehaa414","DOI":"10.1093\/eurheartj\/ehaa414"},{"key":"55902_CR17","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.jcmg.2019.09.005","volume":"13","author":"J Ramchand","year":"2020","unstructured":"Ramchand, J. et al. Plasma ACE2 Activity Predicts Mortality in Aortic Stenosis and Is Associated With Severe Myocardial Fibrosis. JACC Cardiovasc. Imaging. 13, 655\u2013664 (2020).","journal-title":"JACC Cardiovasc. Imaging"},{"key":"55902_CR18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11357-020-00300-2","volume":"43","author":"M Fagyas","year":"2021","unstructured":"Fagyas, M. et al. Level of the SARS-CoV-2 receptor ACE2 activity is highly elevated in old-aged patients with aortic stenosis: implications for ACE2 as a biomarker for the severity of COVID-19. Geroscience 43, 19\u201329 (2021).","journal-title":"Geroscience"},{"key":"55902_CR19","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1172\/JCI114844","volume":"86","author":"B Rigat","year":"1990","unstructured":"Rigat, B. et al. An insertion\/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J. Clin. Invest. 86, 1343\u20131346 (1990).","journal-title":"J. Clin. Invest."},{"key":"55902_CR20","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s004390000358","volume":"107","author":"K Uemura","year":"2000","unstructured":"Uemura, K., Nakura, J., Kohara, K. & Miki, T. Association of ACE I\/D polymorphism with cardiovascular risk factors. Hum. Genet. 107, 239\u2013242 (2000).","journal-title":"Hum. Genet."},{"key":"55902_CR21","first-page":"205","volume":"48","author":"T Isbir","year":"1999","unstructured":"Isbir, T., Yilmaz, H., Agachan, B., Aydin, M. & Isbir, C. S. Association Between Angiotensin-Converting Enzyme Gene Polymorphism and Coronary Artery Disease. IUBMB Life. 48, 205\u2013207 (1999).","journal-title":"IUBMB Life"},{"key":"55902_CR22","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/S0008-6363(99)00055-3","volume":"43","author":"F Perticone","year":"1999","unstructured":"Perticone, F. Hypertensive left ventricular remodeling and ACE-gene polymorphism. Cardiovasc. Res. 43, 192\u2013199 (1999).","journal-title":"Cardiovasc. Res."},{"key":"55902_CR23","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1016\/j.ehj.2004.08.026","volume":"25","author":"AFC Schut","year":"2004","unstructured":"Schut, A. F. C. et al. Angiotensin converting enzyme insertion\/deletion polymorphism and the risk of heart failure in hypertensive subjects. Eur. Heart J. 25, 2143\u20132148 (2004).","journal-title":"Eur. Heart J."},{"key":"55902_CR24","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","volume":"43","author":"A Vahanian","year":"2022","unstructured":"Vahanian, A. et al. 2021 ESC\/EACTS Guidelines for the management of valvular heart disease. Eur. Heart J. 43, 561\u2013632 (2022).","journal-title":"Eur. Heart J."},{"key":"55902_CR25","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1097\/MNH.0b013e328341164a","volume":"20","author":"C Tikellis","year":"2011","unstructured":"Tikellis, C., Bernardi, S. & Burns, W. C. Angiotensin-converting enzyme 2 is a key modulator of the renin\u2013angiotensin system in cardiovascular and renal disease. Curr. Opin. Nephrol. Hypertens. 20, 62\u201368 (2011).","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"55902_CR26","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.3390\/diagnostics14222507","volume":"14","author":"RM Christodorescu","year":"2024","unstructured":"Christodorescu, R. M. et al. Clinical and Demographic Characteristics of Patients Hospitalized for Decompensated Heart Failure with Extremely High NT-proBNP Levels. Diagnostics 14, 2507 (2024).","journal-title":"Diagnostics"},{"key":"55902_CR27","doi-asserted-by":"crossref","unstructured":"B\u00e1nhegyi, V. et al. Human tissue angiotensin converting enzyme (ACE) activity is regulated by genetic polymorphisms, posttranslational modifications, endogenous inhibitors and secretion in the serum, lungs and heart. Cells 10, (2021).","DOI":"10.3390\/cells10071708"},{"key":"55902_CR28","doi-asserted-by":"crossref","unstructured":"Enyedi, E. E. et al. ACE Phenotyping in Human Blood and Tissues: Revelation of ACE Outliers and Sex Differences in ACE Sialylation. Biomedicines 12, (2024).","DOI":"10.3390\/biomedicines12050940"},{"key":"55902_CR29","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.amjcard.2006.01.059","volume":"98","author":"CM Ferrario","year":"2006","unstructured":"Ferrario, C. M. & Strawn, W. B. Role of the Renin-Angiotensin-Aldosterone System and Proinflammatory Mediators in Cardiovascular Disease. Am. J. Cardiol. 98, 121\u2013128 (2006).","journal-title":"Am. J. Cardiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55902-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55902-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55902-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T23:53:22Z","timestamp":1786492402000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55902-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["55902"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-55902-1","relation":{"references":[{"id-type":"doi","id":"10.1152\/physrev.00036","asserted-by":"subject"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,1]]},"assertion":[{"value":"16 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol received approval from the Ethics Committee of Iuliu Ha\u0163ieganu University of Medicine and Pharmacy Cluj-Napoca (Approval No. 76\/14 March 2022) and from the Heart Institute of Cluj-Napoca (Approval No. 4540\/12 April 2022). The study was carried out in accordance with the principles outlined in the Declaration of Hel-sinki.","order":2,"name":"Ethics","label":"Institutional Review Board Statement","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"25030"}}